SAN DIEGO--(BUSINESS WIRE)--ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD), a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders, today announced that it will present at the BIO CEO & Investor Conference 2010 on Monday, February 8, 2010, at 3:00 p.m. Eastern Time at The Waldorf=Astoria Hotel in New York City. A live webcast of ACADIA’s presentation will be accessible on the compa
For more information, please visit
http://www.businesswire.com/news/home/20100201005516/en